Form 8-K - Current report:
SEC Accession No. 0001096906-24-000119
Filing Date
2024-01-29
Accepted
2024-01-29 16:15:36
Documents
15
Period of Report
2024-01-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 LFTD PARTNERS INC. - FORM 8-K SEC FILING lsfp-20240123.htm   iXBRL 8-K 34567
  Complete submission text file 0001096906-24-000119.txt   167004

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lsfp-20240123_def.xml EX-101.DEF 1845
3 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT lsfp-20240123_lab.xml EX-101.LAB 20183
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lsfp-20240123_pre.xml EX-101.PRE 13397
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lsfp-20240123.xsd EX-101.SCH 2381
17 EXTRACTED XBRL INSTANCE DOCUMENT lsfp-20240123_htm.xml XML 2557
Mailing Address 4227 HABANA AVENUE JACKSONVILLE FL 32217
Business Address 4227 HABANA AVENUE JACKSONVILLE FL 32217 8479152446
LFTD PARTNERS INC. (Filer) CIK: 0001391135 (see all company filings)

EIN.: 870479286 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52520 | Film No.: 24573843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)